De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"De‐escalation Treatment Protocols for Human Papillomavirus‐associated Oropharyngeal Squamous Cell Carcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437504/all/De‐escalation_treatment_protocols_for_human_papillomavirus‐associated_oropharyngeal_squamous_cell_carcinoma.
De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437504/all/De‐escalation_treatment_protocols_for_human_papillomavirus‐associated_oropharyngeal_squamous_cell_carcinoma. Accessed January 15, 2026.
De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437504/all/De‐escalation_treatment_protocols_for_human_papillomavirus‐associated_oropharyngeal_squamous_cell_carcinoma
De‐escalation Treatment Protocols for Human Papillomavirus‐associated Oropharyngeal Squamous Cell Carcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437504/all/De‐escalation_treatment_protocols_for_human_papillomavirus‐associated_oropharyngeal_squamous_cell_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma
ID - 437504
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437504/all/De‐escalation_treatment_protocols_for_human_papillomavirus‐associated_oropharyngeal_squamous_cell_carcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

